Although the frequent occurrence of CDC45 overexpression in malignant tumors and its established correlation with poor overall survival has been systematically elucidated in pan-cancers (Lu et al., 2022), further systematic research of CDC45 molecular biological function and clinical application in GC are warranted. The gene discussed is CDC45; the disease is gastric cancer.